Antimitochondrial antibody recognition and structural integrity of the inner lipoyl domain of the E2 subunit of pyruvate dehydrogenase complex

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2126-2133

  Wang, Jinjun ^a   Budamagunta, Madhu S ^a   Voss, John C ^a   Kurth, Mark J ^b   Lam, Kit S ^a   Lu, Ling ^c   Kenny, Thomas P ^a   Bowlus, Christopher ^d   Kikuchi, Kentaro ^e   Coppel, Ross L ^f   Ansari, Aftab A ^g   Gershwin, M Eric ^a   Leung, Patrick S C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NANJING NORMAL UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TEIKYO UNIVERSITY   (Japan)

^f MONASH UNIVERSITY   (Australia)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLUTAMIC ACID; IMMUNOGLOBULIN G; ISOLEUCINE; MITOCHONDRION ANTIBODY; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE COMPLEX E2 SUBUNIT; UNCLASSIFIED DRUG;

ANTIBODY RECOGNITION; ANTIGEN RECOGNITION; ARTICLE; BILIARY CIRRHOSIS; CONTROLLED STUDY; CROHN DISEASE; ELECTRON SPIN RESONANCE; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MUTANT; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; SCLERODERMA; SITE DIRECTED MUTAGENESIS; SPIN LABELING; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84883432491     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301092     Document Type: Article

References (39)

1. Gershwin, M. E., and I. R. Mackay. 2008. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47: 737-745.
2. Gershwin, M. E., I. R. Mackay, A. Sturgess, and R. L. Coppel. 1987. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J. Immunol. 138: 3525-3531.
3. Leung, P. S., D. T. Chuang, R. M. Wynn, S. Cha, D. J. Danner, A. Ansari, R. L. Coppel, and M. E. Gershwin. 1995. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 22: 505-513.
4. Moteki, S., P. S. Leung, E. R. Dickson, D. H. Van Thiel, C. Galperin, T. Buch, D. Alarcon-Segovia, D. Kershenobich, K. Kawano, R. L. Coppel, et al. 1996. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Hepatology 23: 436-444.
5. Oertelt, S., R. Rieger, C. Selmi, P. Invernizzi, A. A. Ansari, R. L. Coppel, M. Podda, P. S. Leung, and M. E. Gershwin. 2007. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45: 659-665.
6. Van de Water, J., M. E. Gershwin, P. Leung, A. Ansari, and R. L. Coppel. 1988. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J. Exp. Med. 167: 1791-1799.
7. Hirschfield, G. M., and M. E. Gershwin. 2013. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu. Rev. Pathol. 8: 303-330.
8. Benson, G. D., K. Kikuchi, H. Miyakawa, A. Tanaka, M. R. Watnik, and M. E. Gershwin. 2004. Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. Clin. Dev. Immunol. 11: 129-133.
9. Leung, P. S., J. Wang, P. Naiyanetr, T. P. Kenny, K. S. Lam, M. J. Kurth, and M. E. Gershwin. 2013. Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J. Autoimmun. 41: 79-86.
10. Leung, P. S., K. Lam, M. J. Kurth, R. L. Coppel, and M. E. Gershwin. 2012. Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis? Trends Mol. Med. 18: 577-582.
11. Howard, M. J., C. Fuller, R. W. Broadhurst, R. N. Perham, J. G. Tang, J. Quinn, A. G. Diamond, and S. J. Yeaman. 1998. Three-dimensional structure of the major autoantigen in primary biliary cirrhosis. Gastroenterology 115: 139-146.
12. Mao, T. K., P. A. Davis, J. A. Odin, R. L. Coppel, and M. E. Gershwin. 2004. Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology 40: 1241-1248.
13. Naiyanetr, P., J. D. Butler, L. Meng, J. Pfeiff, T. P. Kenny, K. G. Guggenheim, R. Reiger, K. Lam, M. J. Kurth, A. A. Ansari, et al. 2011. Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. J. Autoimmun. 37: 209-216.
14. Kaplan, M. M., and M. E. Gershwin. 2005. Primary biliary cirrhosis. N. Engl. J. Med. 353: 1261-1273.
15. Bambha, K., W. R. Kim, J. Talwalkar, H. Torgerson, J. T. Benson, T. M. Therneau, E. V. Loftus, Jr., B. P. Yawn, E. R. Dickson, and L. J. Melton, III. 2003. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 125: 1364-1369.
16. Leung, P. S., L. Rossaro, P. A. Davis, O. Park, A. Tanaka, K. Kikuchi, H. Miyakawa, G. L. Norman, W. Lee, and M. E. Gershwin; Acute Liver Failure Study Group. 2007. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 46: 1436-1442.
17. Stravitz, R. T., J. H. Lefkowitch, R. J. Fontana, M. E. Gershwin, P. S. Leung, R. K. Sterling, M. P. Manns, G. L. Norman, and W. M. Lee; Acute Liver Failure Study Group. 2011. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 53: 517-526.
18. Moteki, S., P. S. Leung, R. L. Coppel, E. R. Dickson, M. M. Kaplan, S. Munoz, and M. E. Gershwin. 1996. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 24: 97-103.
19. Sasaki, M., J. Van De Water, T. P. Kenny, M. L. Gallo, P. S. Leung, Y. Nakanuma, A. A. Ansari, R. L. Coppel, J. Neuberger, and M. E. Gershwin. 2001. Immunoglobulin gene usage and immunohistochemical characteristics of human monoclonal antibodies to the mitochondrial autoantigens of primary biliary cirrhosis induced in the XenoMouse. Hepatology 34: 631-637.
20. Hess, J. F., M. S. Budamagunta, A. Aziz, P. G. FitzGerald, and J. C. Voss. 2013. Electron paramagnetic resonance analysis of the vimentin tail domain reveals points of order in a largely disordered region and conformational adaptation upon filament assembly. Protein Sci. 22: 47-55.
21. Acar, S., D. B. Carlson, M. S. Budamagunta, V. Yarov-Yarovoy, J. J. Correia, M. R. Niñonuevo, W. Jia, L. Tao, J. A. Leary, J. C. Voss, et al. 2013. The bipolar assembly domain of the mitotic motor kinesin-5. Nat Commun. 4: 1343.
22. Chen, H. K., Z. Liu, A. Meyer-Franke, J. Brodbeck, R. D. Miranda, J. G. McGuire, M. A. Pleiss, Z. S. Ji, M. E. Balestra, D. W. Walker, et al. 2012. Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J. Biol. Chem. 287: 5253-5266.
23. Aziz, A., J. F. Hess, M. S. Budamagunta, J. C. Voss, A. P. Kuzin, Y. J. Huang, R. Xiao, G. T. Montelione, P. G. FitzGerald, and J. F. Hunt. 2012. The structure of vimentin linker 1 and rod 1B domains characterized by site-directed spinlabeling electron paramagnetic resonance (SDSL-EPR) and X-ray crystallography. J. Biol. Chem. 287: 28349-28361.
24. Nygaard, E. B., J. O. Lagerstedt, G. Bjerre, B. Shi, M. Budamagunta, K. A. Poulsen, S. Meinild, R. R. Rigor, J. C. Voss, P. M. Cala, and S. F. Pedersen. 2011. Structural modeling and electron paramagnetic resonance spectroscopy of the human Na+/H+ exchanger isoform 1, NHE1. J. Biol. Chem. 286: 634-648.
25. Aziz, A., J. F. Hess, M. S. Budamagunta, P. G. FitzGerald, and J. C. Voss. 2009. Head and rod 1 interactions in vimentin: identification of contact sites, structure, and changes with phosphorylation using site-directed spin labeling and electron paramagnetic resonance. J. Biol. Chem. 284: 7330-7338.
26. Petrlova, J., H. S. Hong, D. A. Bricarello, G. Harishchandra, G. A. Lorigan, L. W. Jin, and J. C. Voss. 2011. A differential association of Apolipoprotein E isoforms with the amyloid-b oligomer in solution. Proteins 79: 402-416.
27. Bogdanos, D., T. Pusl, C. Rust, D. Vergani, and U. Beuers. 2008. Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J. Hepatol. 49: 466-473.
28. Bogdanos, D. P., H. Baum, M. Okamoto, P. Montalto, U. C. Sharma, E. I. Rigopoulou, J. Vlachogiannakos, Y. Ma, A. K. Burroughs, and D. Vergani. 2005. Primary biliary cirrhosis is characterized by IgG3 antibodies crossreactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 42: 458-465.
29. Bogdanos, D. P., H. Baum, D. Vergani, and A. K. Burroughs. 2010. The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis. Markers 29: 301-311.
30. Padgett, K. A., C. Selmi, T. P. Kenny, P. S. Leung, D. L. Balkwill, A. A. Ansari, R. L. Coppel, and M. E. Gershwin. 2005. Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J. Autoimmun. 24: 209-219.
31. Leung, P. S., O. Park, S. Matsumura, A. A. Ansari, R. L. Coppel, and M. E. Gershwin. 2003. Is there a relation between Chlamydia infection and primary biliary cirrhosis? Clin. Dev. Immunol. 10: 227-233.
32. Abdulkarim, A. S., L. M. Petrovic, W. R. Kim, P. Angulo, R. V. Lloyd, and K. D. Lindor. 2004. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J. Hepatol. 40: 380-384.
33. Fussey, S. P., S. T. Ali, J. R. Guest, O. F. James, M. F. Bassendine, and S. J. Yeaman. 1990. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc. Natl. Acad. Sci. USA 87: 3987-3991.
34. Cha, S., P. S. Leung, M. E. Gershwin, M. P. Fletcher, A. A. Ansari, and R. L. Coppel. 1993. Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis. Proc. Natl. Acad. Sci. USA 90: 2527-2531.
35. Cha, S., P. S. Leung, R. L. Coppel, J. Van de Water, A. A. Ansari, and M. E. Gershwin. 1994. Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis. Hepatology 20: 574-583.
36. Fussey, S. P., J. G. Lindsay, C. Fuller, R. N. Perham, S. Dale, O. F. James, M. F. Bassendine, and S. J. Yeaman. 1991. Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. Hepatology 13: 467-474.
37. Duarte-Rey, C., D. Bogdanos, C. Y. Yang, K. Roberts, P. S. Leung, J. M. Anaya, H. J. Worman, and M. E. Gershwin. 2012. Primary biliary cirrhosis and the nuclear pore complex. Autoimmun. Rev. 11: 898-902.
38. Moritoki, Y., Z. X. Lian, H. Wulff, G. X. Yang, Y. H. Chuang, R. Y. Lan, Y. Ueno, A. A. Ansari, R. L. Coppel, I. R. Mackay, and M. E. Gershwin. 2007. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology 45: 314-322.
39. You, Z., Q. Wang, Z. Bian, Y. Liu, X. Han, Y. Peng, L. Shen, X. Chen, D. Qiu, C. Selmi, et al. 2012. The immunopathology of liver granulomas in primary biliary cirrhosis. J. Autoimmun. 39: 216-221.